Know Cancer

or
forgot password

    • cancer clinical trials in charlotte, NC

    • A Study of Abatacept in Patients With Active Crohn's Disease
    Charlotte Gastroenterology & Hepatology, Pllc
    Charlotte, North Carolina 28207
    Crohn's Disease
    Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis
    Site Ref # / Investigator 3752
    Charlotte, North Carolina 28207
    Ulcerative Colitis
    A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease

    Charlotte, North Carolina
    Lymphoma, Non-Hodgkin, Multiple Myeloma, Giant Lymph Node Hyperplasia
    S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Prostate Cancer
    A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies
    Site Reference ID/Investigator# 4934
    Charlotte, North Carolina 28204
    Small Cell Lung Cancer, Small Cell Lung Carcinoma
    Assessment and Tracking of Long-term Alefacept Safety
    Curtis W. Schupbach- MD
    Charlotte, North Carolina 28204
    Psoriasis
    Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Sarcoma
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Blumenthal Cancer Center at Carolinas Medical Center

    Trial Locations
    Blumenthal Cancer Center at Carolinas Medical Center
    Presbyterian Cancer Center at Presbyterian Hospital
    Leukemia
    Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Cervical Cancer
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Blumenthal Cancer Center at Carolinas Medical Center

    Trial Locations
    Blumenthal Cancer Center at Carolinas Medical Center
    Presbyterian Cancer Center at Presbyterian Hospital
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Study of EC145 in Patients With Progressive Adenocarcinoma of the Lung
    Blumenthal Cancer Center
    Charlotte, North Carolina 28203
    Adenocarcinoma of the Lung
    Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
    Site Reference ID/Investigator# 6184
    Charlotte, North Carolina 28211
    Non-Small Cell Lung Cancer (NSCLC)
    Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
    Carolina Hematology & Oncology Associates
    Charlotte, North Carolina 28203
    Melanoma
    Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer
    Carolina Neurosurgery & Spine Associates
    Charlotte, North Carolina 28204
    Metastatic Brain Cancer
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
    Carolinas Medical Center (CMC)/Neurosciences & Spine Institute (NSSI)
    Charlotte, North Carolina
    Multiple Sclerosis, Relapsing-Remitting
    Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis
    Arthritis Clinic & Carolina Bone & Joint, Pa
    Charlotte, North Carolina 28210
    Psoriatic Arthritis
    RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases
    Presbyterian Health Care
    Charlotte, North Carolina 28204
    Brain Metastases
    Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer
    Presbyterian Healthcare
    Charlotte, North Carolina 28233-3549
    Carcinoma, Non-Small-Cell Lung
    Phase II Dasatinib Study in Advanced Breast Cancer
    Presbyterian Health Care
    Charlotte, North Carolina 28204
    Advanced Breast Cancer
    Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen
    Sanofi-Aventis Investigational Site Number 840024
    Charlotte, North Carolina 28204
    Colorectal Neoplasms, Neoplasm Metastasis
    Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Treatment of Advanced Renal Cell Carcinoma With Quinacrine
    ClinWorks Cancer Research Center
    Charlotte, North Carolina 28207
    Renal Cell Carcinoma
    GAUSS: A Study of RO5072759 in Patients With Indolent Non-Hodgkin's Lymphoma

    Charlotte, North Carolina
    Non-Hodgkin's Lymphoma
    Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer

    Charlotte, North Carolina
    Cancer, Neoplasm Metastasis
    Phase II, 2nd Line Melanoma - RAND Monotherapy
    Blumenthal Cancer Center, Carolinas Medical Center
    Charlotte, North Carolina 28204
    Melanoma
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site 079
    Charlotte, North Carolina 28209
    Hypoactive Sexual Desire Disorder
    Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
    Sanofi-Aventis Investigational Site Number 840007
    Charlotte, North Carolina 28204
    Urinary Bladder Neoplasms
    A Study of Leuprolide to Treat Prostate Cancer
    Site Reference ID/Investigator# 8680
    Charlotte, North Carolina 28209
    Prostate Cancer
    A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
    Presbyterian Hospital Center for Cancer Research
    Charlotte, North Carolina 28204
    Androgen-insensitive Prostate Cancer
    Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma
    ClinWorks Cancer Research Center
    Charlotte, North Carolina 28207
    Hodgkin's Lymphomas
    Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myelomonocytic Leukemia (M4), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    ChemoFx® PRO - A Post-Market Data Collection Study
    Blumenthal Cancer Center

    Trial Locations
    Blumenthal Cancer Center
    Presbyterian Gynecologic Oncology
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Uterine Neoplasms, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Cervical Cancer
    Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer
    Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Recurrent Renal Cell Cancer, Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Cognition in the Study of Tamoxifen and Raloxifene
    Presbyterian Hospital

    Trial Locations
    Presbyterian Hospital
    Blumenthal Cancer Center
    Cognition, Aging
    A Phase I/II Study of HE3235 in Patients With Prostate Cancer

    Charlotte, North Carolina
    Prostate Cancer
    Pregnancy in Polycystic Ovary Syndrome II
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Pregnancy, Polycystic Ovary Syndrome
    Platinum Resistant Ovarian Cancer Evaluation of Doxil and EC145 Combination Therapy
    Bluementhal Cancer Center
    Charlotte, North Carolina 28232
    Ovarian Cancer
    Safety and Efficacy Study of Switching From Epzicom to Truvada
    ID Consultants, P.A.
    Charlotte, North Carolina 28209
    HIV Infection
    Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
    Piedmont Oncology Specialists
    Charlotte, North Carolina 28207
    Malignant Melanoma
    FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Colorectal Carcinoma, Liver Metastases
    Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
    Blumenthal Cancer Center at Carolinas Medical Center

    Trial Locations
    Blumenthal Cancer Center at Carolinas Medical Center
    Presbyterian Cancer Center at Presbyterian Hospital
    Sarcoma
    Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer